Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 646 | 691 | 652 | 791 | 397 |
| Income taxes - deferred | 7 | 34 | 3 | 3 | 12 |
| Accounts receivable | 105 | -97 | 62 | -158 | 153 |
| Accounts payable and accrued liabilities | -459 | -377 | 612 | -34 | 451 |
| Other Working Capital | -340 | -726 | 604 | -228 | 660 |
| Other Operating Activity | -4,672 | -6,239 | -4,065 | -4,469 | -3,067 |
| Operating Cash Flow | $-4,714 | $-6,714 | $-2,131 | $-4,095 | $-1,394 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -3 | -1 | -4 | -6 |
| Net Acquisitions | N/A | N/A | 0 | 5 | 58 |
| Other Investing Activity | -2 | -50 | 0 | 0 | 0 |
| Investing Cash Flow | $-12 | $-53 | $-1 | $2 | $53 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 0 | 442 |
| Debt Issued | 10,000 | N/A | 0 | 125 | 285 |
| Debt Repayment | -28 | -871 | -84 | -50 | 0 |
| Common Stock Issued | N/A | 6,580 | 673 | 5,509 | 650 |
| Other Financing Activity | 1,235 | 1,392 | -75 | 0 | 243 |
| Financing Cash Flow | $11,207 | $7,101 | $514 | $5,584 | $1,620 |
| Exchange Rate Effect | 0 | 0 | 0 | -17 | -4 |
| Beginning Cash Position | 464 | 131 | 1,750 | 276 | 2 |
| End Cash Position | 6,946 | 464 | 131 | 1,750 | 276 |
| Net Cash Flow | $6,482 | $333 | $-1,618 | $1,490 | $279 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,714 | -6,714 | -2,131 | -4,095 | -1,394 |
| Capital Expenditure | -10 | -3 | -1 | -4 | -6 |
| Free Cash Flow | -4,724 | -6,717 | -2,132 | -4,099 | -1,399 |